1 – 50 of 86
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors
(
- Contribution to journal › Article
-
Mark
AlphaML : A clear, legible, explainable, transparent, and elucidative binary classification platform for tabular data
(
- Contribution to journal › Article
-
Mark
Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells
(
- Contribution to journal › Article
- 2023
-
Mark
A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
(
- Contribution to journal › Article
-
Mark
AI-Driven Drug Response Prediction for Personalized Cancer Medicine
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer
(
- Contribution to journal › Article
-
Mark
Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling
(
- Contribution to journal › Article
-
Mark
Understanding the Role of Activation Loop Mutants in Drug Efficacy for FLT3-ITD
(
- Contribution to journal › Article
-
Mark
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
(
- Contribution to journal › Article
- 2022
-
Mark
Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
(
- Contribution to journal › Scientific review
-
Mark
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
(
- Contribution to journal › Article
- 2021
-
Mark
Machine learning in the prediction of cancer therapy
(
- Contribution to journal › Scientific review
-
Mark
T cell receptor (TCR) signaling in health and disease
(
- Contribution to journal › Scientific review
-
Mark
The Aurora kinase/β-catenin axis contributes to dexamethasone resistance in leukemia
(
- Contribution to journal › Article
- 2020
-
Mark
Mechanisms of anticancer therapy resistance : the role of cancer stem cells
(
- Contribution to journal › Debate/Note/Editorial
- 2019
-
Mark
The role of SRC family kinases in FLT3 signaling
(
- Contribution to journal › Scientific review
-
Mark
The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
(
- Contribution to journal › Letter
-
Mark
Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
(
- Contribution to journal › Article
-
Mark
FMS-like Tyrosine Kinase 3/FLT3 : From Basic Science to Clinical Implications
(
- Contribution to journal › Article
-
Mark
Metallopeptidase inhibitor 1 (TIMP-1) promotes receptor tyrosine kinase c-Kit signaling in colorectal cancer
(
- Contribution to journal › Article
- 2018
-
Mark
SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
(
- Contribution to journal › Article
-
Mark
Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression
(
- Contribution to journal › Letter
-
Mark
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
(
- Contribution to journal › Article
-
Mark
Bruton’s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma
(
- Contribution to journal › Article
- 2017
-
Mark
The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)
(
- Contribution to journal › Article
-
Mark
ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling
(
- Contribution to journal › Article
-
Mark
Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
(
- Contribution to journal › Article
-
Mark
T-cell acute lymphoblastic leukemia cells display activation of different survival pathways
(
- Contribution to journal › Article
-
Mark
KITD816V induces SRC-mediated tyrosine phosphorylation of MITF and altered transcription program in melanoma
(
- Contribution to journal › Article
-
Mark
BEX3
2017) p.1-4(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Efficacy of the CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
(
- Contribution to journal › Article
- 2016
-
Mark
FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
GRB10
2016) p.1-4(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
FMS-Like Tyrosine Kinase-3
2016) p.1-4(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Kit
2016) p.1-5(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling
(
- Contribution to journal › Article
-
Mark
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
(
- Contribution to journal › Scientific review
-
Mark
Expression of GADS enhances FLT3-induced mitogenic signaling.
(
- Contribution to journal › Article
-
Mark
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
(
- Contribution to journal › Article
-
Mark
Src-Like Adapter Protein (SLAP)
2016) p.1-4(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Src-Like Adapter Protein 2 (SLAP2)
(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells.
(
- Contribution to journal › Article
- 2015
-
Mark
SOCS6 (suppressor of cytokine signaling 6)
(
- Contribution to journal › Scientific review
-
Mark
Brain-Expressed X-linked (BEX) proteins in human cancers.
(
- Contribution to journal › Scientific review
-
Mark
Role of SRC-like adaptor protein (SLAP) in immune and malignant cell signaling.
(
- Contribution to journal › Scientific review
-
Mark
PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner.
(
- Contribution to journal › Article
-
Mark
BEX1 acts as a tumor suppressor in acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
The Phosphatases STS1 and STS2 Regulate Hematopoietic Stem and Progenitor Cell Fitness.
(
- Contribution to journal › Article
-
Mark
The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.
(
- Contribution to journal › Article